Loading...

Hyperfine, Inc.

HYPR•NASDAQ
Healthcare
Medical - Devices
$1.44
$0.14(10.77%)
U.S. Market opens in 9h 51m

Hyperfine, Inc. (HYPR) Stock Overview

Explore Hyperfine, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap117.7M
P/E Ratio-3.69
EPS (TTM)$-0.43
ROE-0.97%
Fundamental Analysis

AI Price Forecasts

1 Month$0.79
3 Months$0.79
1 Year Target$1.01

HYPR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Hyperfine, Inc. (HYPR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 71.51, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $1.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.69 and a market capitalization of 117.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
10.77%
5-Day Change
11.63%
1-Month Change
29.73%
3-Month Change
21.008%
6-Month Change
24.14%
Year-to-Date (YTD) Change
47.04%
1-Year Change
97.02%
3-Year Change
2.86%
5-Year Change
-85.54%
All-Time (Max) Change
-85.61%

Contact Information

https://hyperfine.io
203-458-7100
351 New Whitfield Street, Guilford, CT, 06437

Company Facts

111 Employees
IPO DateJan 28, 2021
CountryUS
Actively Trading

Frequently Asked Questions